Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Dec;4(4):147-152.
doi: 10.1016/j.ijpam.2017.09.002. Epub 2017 Dec 15.

Polycystic ovary syndrome: Pelvic MRI as alternative to pelvic ultrasound for the diagnosis in overweight and obese adolescent girls

Simon Kayemba-Kay's  1   2 , Armelle Pambou  3 , Anne Heron  2   4 , Sidi Mohammed Benosman  5
Affiliations
Case Reports

Polycystic ovary syndrome: Pelvic MRI as alternative to pelvic ultrasound for the diagnosis in overweight and obese adolescent girls

Simon Kayemba-Kay's et al. Int J Pediatr Adolesc Med. 2017 Dec.

Abstract

Background: Polycystic ovary syndrome (PCOS) is a common reproductive endocrinopathy in women of childbearing age, affecting 5-15% women in this age group. Suggestive cardinal features comprise hyperandrogenism, ovulatory dysfunction and/or polycystic ovary appearance. The gold standard radiological tool is the pelvic ultrasound (PUS) whose yield may be limited in overweight and obese adolescent girls.

Objective and hypotheses: To evaluate the contribution of pelvic MRI to the diagnosis of PCOS in a specific group of virginal overweight and obese adolescent girls.

Method: Eight adolescent girls seen for menstrual irregularities or amenorrhea, with features of hyperandrogenism were biochemically screened (LH, FSH, testosterone, S-DHEA, delta-4 androstenedione, 17 (OH) P, SHBG, TSH, free T4, prolactin and lipid profile, fasting blood sugar and HOMA-IR and HOMA-B). Each had PUS and/or pelvic MRI (PMRI) performed. Other causes of hyperandrogenism were excluded.

Imaging: PUS with the trans-abdominal transducer was attempted in only one patient Acuson© scanner, using 3.5-7.5 MHz transducer; PMRI was performed in all patients with phased array coil of 1.5 T Siemens MRI scanner, with T1 and T2-weighted axial and coronal images. PCOS was defined according to the Rotterdam PCOS consensus Workshop.

Results: Eight girls (mean age 14,6 ± 1.47 years) are reported, one was overweight (BMI Z-score > 1 SDS), seven others were obese (BMI Z-score > 2 SDS). Mean age at menarche was 11.58 ± 1.11 years, except for one who had not yet entered menarche. All had menstrual irregularities, acanthosis nigricans, acne, hirsutism, and biochemical characteristics of PCOS (high plasma androgens, insulin resistance, glucose/insulin ratio <4.5, decreased SHBG).PUS was not contributive to the diagnosis of PCOS, whereas PMRI showed typical aspect (well delineated peripheral ovarian cysts), with increased ovarian volume and stroma.

Conclusion: Although PUS remains the gold standard for the diagnosis of PCOS in most cases, its limitations in overweight and obese girls are real and must be considered.If utilization of endovaginal transducer not being feasible in young virginal girls, PMRI could be a useful alternative, allowing greater delineation of structural components of the ovary and better appreciation of both its volume and structural alterations.

Keywords: Adolescents; Adolescents girls; Diagnosis; Menstrual irregularities; Obesity; Overweight; PCOS; Pelvic MRI.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
T2-weighted image showing excess in subcutaneous abdominal fat.
Fig. 2
Fig. 2
T2-weighted image showing multiple peripherally located ovarian cysts with increased stromal volume, axial section (A), and sagittal section (B).
Fig. 3
Fig. 3
T2 weighted axial section image showing peripherally located ovarian cysts in an obese adolescent girl (A & B).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Fauser B.C., Tarlatzis R.W., Rebar R.S. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS consensus workshop group. Fertil Steril. 2012;97 28–38.e25. - PubMed
    1. Azziz R., Sanchez E.S., Knochenhauer C. Androgen excess in women: experience with over 1,000 consecutive patients. J Clin Endocrinol Metab. 2004;89:453–462. - PubMed
    1. Carmina E., Rosato F., Janni A., Rizzo M., Longo R.A. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab. 2006;91:2–6. - PubMed
    1. Hashemipour M., Faghihimani S., Zolfaghary B., Hovsepian S., Ahamadi F., Haghighi S. Prevalence of polycystic ovary syndrome in girls aged 14–18 years in Isfahan Iran. Horm Res. 2004;62:278–282. - PubMed
    1. Driscoll D.A. Polycystic ovary syndrome in adolescence. Ann N. Y Acad Sci. 2003;997:49–55. - PubMed

Publication types